GlassScriptPhysician profile
Lisa M Lewis
NPI 1003857244
$3,994.32
in general payments reported to CMS, 2019-2025
24 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $794 · 2022: $836 · 2023: $745 · 2024: $1,044 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,285 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,285.19 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $769.27 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $454.12 | 2021-2024 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $386.82 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $328.96 | 2022-2024 | Sotyktu |
| Amgen INC. | $231.10 | 2021-2025 | Otezla, Enbrel, Otezla |
| Leo Pharma INC. | $214.12 | 2021-2025 | Adbry |
| Incyte Corporation | $192.92 | 2023-2024 | Opzelura |
| Sun Pharmaceutical Industries INC. | $183.56 | 2021-2024 | Absorica Ld, Winlevi |
| Janssen Biotech, INC. | $169.25 | 2021-2025 | Tremfya |
| Genzyme Corporation | $162.50 | 2021-2023 | |
| Lilly USA, LLC | $159.03 | 2021-2024 | Taltz, Ebglyss |
| Ucb, INC. | $134.39 | 2021-2025 | Bimzelx |
| Mayne Pharma Commercial LLC | $119.48 | 2022-2025 | |
| Pfizer INC. | $119.46 | 2024-2025 | |
| Dermavant Sciences, INC. | $102.11 | 2023-2024 | Vtama |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $76.82 | 2025 | Sofdra |
| Organon LLC | $41.53 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.01 | 2021 | |
| Almirall LLC | $31.37 | 2021-2024 | Seysara |
| Pacira Pharmaceuticals Incorporated | $18.50 | 2025 | Exparel, Iovera |
| Baxter Healthcare | $18.02 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.82 | 2021 | |
| Epi Health, LLC | $15.40 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.